[Adjuvant systemic treatment of primary breast cancer].

Author: MouridsenH T

Paper Details 
Original Abstract of the Article :
Systemic adjuvant therapy has improved the prognosis of patients with primary breast cancer. Meta-analyses have demonstrated that approximately 1/4 of deaths can be avoided among younger women treated with multiple cytotoxic drug regimens and among older women treated with tamoxifen. However, with t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/7825247

データ提供:米国国立医学図書館(NLM)

Adjuvant Systemic Treatment for Breast Cancer

Breast cancer is a prevalent disease that affects millions of women worldwide. This study reviews the effectiveness of [adjuvant systemic therapy] in treating primary breast cancer. Think of it as a comprehensive analysis of various approaches to combatting this disease, like exploring different strategies for surviving in the vast desert of cancer treatment.

Adjuvant Therapy Improves Breast Cancer Outcomes

The study concludes that adjuvant systemic therapy, including chemotherapy and hormone therapy, has significantly improved the prognosis for patients with primary breast cancer. While acknowledging the positive impact of treatment, the study also highlights the need for further research to optimize therapy and address the physical, psychological, and socio-economic consequences of treatment. It's like navigating a challenging desert landscape, where every step requires careful consideration of the terrain and available resources.

Navigating Breast Cancer Treatment

This research provides valuable insights into the multifaceted nature of breast cancer treatment. It encourages a personalized approach, considering individual patient needs and the potential long-term effects of therapy. It's like having a knowledgeable guide in the desert, providing support and guidance through the complexities of treatment and recovery.

Dr. Camel's Conclusion

This review underscores the significant progress made in treating breast cancer but emphasizes the need for continuous research to improve patient outcomes and address the multifaceted challenges associated with this disease. It's like exploring new paths in the vast desert of cancer research, seeking better ways to heal and support those affected by this disease.

Date :
  1. Date Completed 1995-02-16
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

7825247

DOI: Digital Object Identifier

7825247

Related Literature

SNS
PICO Info
in preparation
Languages

Danish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.